<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01641835</url>
  </required_header>
  <id_info>
    <org_study_id>S-2012-1 NORM-cc</org_study_id>
    <nct_id>NCT01641835</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography (OCT) Data Collection Study</brief_title>
  <official_title>Optical Coherence Tomography (OCT) Data Collection Study &quot;S-2012-1 Norm-cc&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg Engineering GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg Engineering GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collect OCT data to evaluate the range and age trend of ocular measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center study. Ocular history and examination will be conducted
      on consented subjects to determine further participation in the study. Subjects qualified to
      continue will undergo imaging of both eyes using the SPECTRALIS OCT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Endpoints</measure>
    <time_frame>3 months</time_frame>
    <description>The primary endpoints are the structural measurement values of (1) the ONH, (2) the peri-papillary RNFL, and (3) the macula obtained using the Spectralis OCT and the statistical descriptors such as mean, standard deviation, and distribution percentiles.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bruch's Membrane Opening - Minimum Rim Area, Global</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">303</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Normals</arm_group_label>
    <description>No eye disease.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        No eye disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is not an employee of the eye clinic.

          -  Age ≥18 to 90.

          -  Able and willing to undergo the test procedures, give consent, and to follow
             instructions.

          -  Healthy eye without prior intraocular surgery (except cataract surgery and Lasik) and
             without clinically significant vitreal, retinal or choroidal diseases, diabetic
             retinopathy, or disease of the optic nerve.

          -  Caucasian decent (self-reported).

          -  Negative history of glaucoma.

          -  Intraocular pressure ≤21mmHg.

          -  Best corrected visual acuity ≥0.5.

          -  Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.

          -  Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal
             limits.

          -  Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim
             with respect to color and shape. The optic disc is examined ophthalmoscopically and by
             evaluation of stereo photographs.

          -  When both eyes are eligible, both eyes enter the study for inter-eye asymmetry; one
             randomly selected eye will be used for all other measures.

        Exclusion Criteria:

          -  Unreliable visual field. The reliability indices should be used as guide as well as
             the perimetrist's notes.

          -  Unusable disc stereo photos.

          -  Inability to undergo the tests.

          -  Insufficient quality of Spectralis OCT images (this is not determined until after
             Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:

               -  Retina completely included in image frame,

               -  Quality Score ≥ 20 in the stored ART mean images, and

               -  For ONH-R scan: Center position error ≤ 100 μm.

          -  Note: Inability of a subject to perform one of the two scan patterns or insufficient
             image quality in one scan pattern does not exclude the subject or eye from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Balwantray Chauhan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dalhousie University, Halifax, NS, Canada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claude Burgoyne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Devers Eye Institute, Portland, OR, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Girkin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Callahan Eye Foundation Hospital, Birmingham, AL, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Mardin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augenklinik des Universitätsklinikums Erlangen, Erlangen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander Scheuerle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsaugenklinik, Heidelberg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dalhousie University</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2012</study_first_submitted>
  <study_first_submitted_qc>July 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2012</study_first_posted>
  <results_first_submitted>August 1, 2014</results_first_submitted>
  <results_first_submitted_qc>October 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 19, 2016</results_first_posted>
  <last_update_submitted>October 26, 2016</last_update_submitted>
  <last_update_submitted_qc>October 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Normals</title>
          <description>No eye disease.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="303"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="303"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Normals</title>
          <description>No eye disease.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="303"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="195"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="150"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Subjects of Caucasian descent</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="303"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Endpoints</title>
        <description>The primary endpoints are the structural measurement values of (1) the ONH, (2) the peri-papillary RNFL, and (3) the macula obtained using the Spectralis OCT and the statistical descriptors such as mean, standard deviation, and distribution percentiles.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Volunteers</title>
            <description>Healthy eye without prior intraocular surgery (except cataract surgery and Lasik) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Endpoints</title>
          <description>The primary endpoints are the structural measurement values of (1) the ONH, (2) the peri-papillary RNFL, and (3) the macula obtained using the Spectralis OCT and the statistical descriptors such as mean, standard deviation, and distribution percentiles.</description>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>peri-papillary RNFL thickness, 12mm circle scan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.2" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>peri-papillary RNFL thickness, 14mm circle scan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.9" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>peri-papillary RNFL thickness, 16mm circle scan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.9" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bruch's Membrane Opening - Minimum Rim Width, glob</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="336.1" spread="51.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Macula parameters have not been analyzed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Posterior pole volume scans and macula volume scanshave been performed in order to allow future analysis of these data. This analysis was not performed yet and analysis is not planned at the moment.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Bruch's Membrane Opening - Minimum Rim Area, Global</title>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Volunteers</title>
            <description>Healthy eye without prior intraocular surgery (except cataract surgery and Lasik) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve</description>
          </group>
        </group_list>
        <measure>
          <title>Bruch's Membrane Opening - Minimum Rim Area, Global</title>
          <units>microns^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1339.3" spread="197.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Normals</title>
          <description>No adverse events were reported.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Gerhard Zinser, PhD</name_or_title>
      <organization>Heidelberg Engineering GmbH</organization>
      <phone>+4962216463 ext 0</phone>
      <email>Contact@HeidelbergEngineering.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

